Sowell, Elizabeth
Professor of Pediatrics, Neurology, and Psychology
My resaerch focuses on how the human brain develops and how it relates to functioning in the developmental environment. I am the principal invcestigator of the Adolescent Brain Cognitive Development (ABCD) study at CHLA within the department of Pediatrics at the Keck School of Medicine at USC. I am particularly interested in the impact of socioeconomic status and environmental toxins on pre and post-natal brain development.
Thompson, Paul
Paul Thompson is a Professor in the Keck School of Medicine of USC. His team’s research projects focus on the neuroscience, mathematics, computer science, software engineering and clinical aspects of neuroimaging and brain mapping. Honored with the 2023 Pioneer in Medicine Award of the Society of Brain Mapping and Therapeutics, and the U.S. Alzheimer Association’s Zenith Award, Paul Thompson directs the ENIGMA Consortium, a global alliance of 2500 scientists in 47 countries who conduct the largest studies of 30 major brain diseases – ranging from Parkinson’s disease, anorexia, schizophrenia, depression, ADHD, bipolar illness and OCD, to HIV and addictions and their effects in the brain. ENIGMA’s genomic screens of over 70,000 people’s brain scans and genome-wide data (published in Nature Genetics, 2012; Nature, 2015; Science, 2020) have brought together experts from 300 institutions to unearth over 500 genetic variants that affect brain structure, disease risk, and brain connectivity. At USC, Dr. Thompson is a Professor of Neurology, Psychiatry, Radiology, Pediatrics, Engineering, and Ophthalmology, and Director of the ENIGMA Center for Worldwide Medicine, Imaging & Genomics – a $11M NIH Center of Excellence in Big Data Computing. Using worldwide medication screens, ENIGMA discovers factors that affect progression of Alzheimer’s disease and other dementias, schizophrenia, depression and childhood brain disorders. Dr. Thompson also directs AI4AD – an $18M NIH Initiative on AI methods to accelerate Alzheimer’s disease research, discovering novel treatment targets; he directs the India ENIGMA Initiative – large-scale study of brain aging in India. He directs the USC Imaging Genetics Center – a group of 50 scientists in Marina del Rey. His team created the first maps of Alzheimer’s disease and schizophrenia spreading in the living brain, and a method to track brain growth in children. Dr. Thompson has an M.A. in mathematics and Greek and Latin Languages from Oxford University, and a PhD in neuroscience from UCLA.
Toga, Arthur
see websites
Valadez, Emilio
Assistant Professor of Psychology
Our lab focuses on understanding how early risk factors, such as temperament and early adversity, confer risk for future emotional problems among children and adolescents. More specifically, we are interested in how executive functions (assessed with a combination of behavioral, EEG, and MRI measures) moderate the psychiatric impact of early-life risk factors. Three interrelated questions spanning basic and translational work guide our research: 1) How are executive functions supported by the brain? 2) How do early risk factors alter the development of executive functions? 3) How do executive functions interact with early risk to modulate psychiatric outcomes? Ultimately, our work aims to better understand basic cognitive and developmental processes to identify novel target mechanisms for intervention.
Wang, Lu
Assistant Professor of Dentistry
Our lab aims to push the boundary of our understanding of human brain in development and related disorders with discoveries focused on non-neuronal cells, environmental stress, and genetic mutations, leveraging the stem cell-based organoid/PCCO-assembled model in combination with the state-of-art genetic and genomic (single cell level) strategies to expand our knowledge of the cell-cell communication, fate dynamics, and niche homeostatic of the non-neuronal cells (astrocytes and pericytes) in health, and emergency rescue when they are under stress or in disease. Ultimately, our collective efforts, alongside those of others in the field, will pave the way for groundbreaking interventions in the realm of neurological disease.
Yassine, Hussein
We study how APOE4 increases the risk of AD through cell, animal and imaging models and in human clinical trials.
